Previous Article | Next Article ![]()
Infection and Immunity, July 2001, p. 4536-4544, Vol. 69, No. 7
Divisions of
Hematology-Oncology1 and Infectious
Diseases,2 Childrens Hospital Los Angeles,
Los Angeles, California 90027
Received 10 October 2000/Returned for modification 14 December
2000/Accepted 13 March 2001
Candida albicans is an opportunistic pathogen, which
primarily affects neonates and immunocompromised individuals. The
pathogen can invade the central nervous system, resulting in
meningitis. At present, the pathogenesis of C. albicans
meningitis is unclear. We used an in vitro model of the human
blood-brain barrier to investigate the interaction(s) of C. albicans with human brain microvascular endothelial cells (BMEC).
Binding of C. albicans to human BMEC was time and inoculum
dependent. Invasion of C. albicans into human BMEC was
demonstrated by using an enzyme-linked immunosorbent assay based on
fluorescent staining of C. albicans with calcoflour. In
contrast, avirulent Candida mutant strains and
nonpathogenic yeast Saccharomyces cerevisiae were not able to bind and invade human BMEC. Morphological studies revealed that on
association with human BMEC, C. albicans formed germ tubes and was able to bud intracellularly. Transmission electron microscopy showed various stages of C. albicans interactions with
human BMEC, e.g., pseudopod-like structures on human BMEC membrane and
intracellular vacuole-like structures retaining C. albicans. Of interest, C. albicans was able to bud
and develop pseudohyphae inside human BMEC without apparent
morphological changes of the host cells. In addition, C. albicans penetrates through human BMEC monolayers without a
detectable change in transendothelial electrical resistance and inulin
permeability. This is the first demonstration that C. albicans is able to adhere, invade, and transcytose across human
BMEC without affecting monolayer integrity. A complete understanding of
the interaction(s) of C. albicans with human BMEC should
contribute to the understanding of the pathogenic mechanism(s) of
C. albicans meningitis.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.7.4536-4544.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Traversal of Candida albicans across
Human Blood-Brain Barrier In Vitro
*
Corresponding author. Mailing address: Division of
Hematology-Oncology, MS 57, Childrens Hospital Los Angeles, Los
Angeles, CA 90027. Phone: (323) 669-5647. Fax: (323) 953-9940. E-mail: ajong{at}chla.usc.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|